Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The goal of this trial is to gain initial clinical experience regarding the safety and
efficacy of treating type I diabetes in people who have received a kidney transplant by
transplanting islets into a new transplant site in the stomach (gastrointestinal submucosa).
A total of 6 patients will be enrolled in the study and followed for a period of up to 3
years after the last islet transplant.